TrialThoracic cancer2022

A phase II study of anlotinib combined with etoposide and platinum-based regimens in the first-line treatment of extensive-stage small cell lung cancer.

Chang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.